Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 121-132 of 1746 results.
"In this 2:1 matched case-control study of hospitalized hemodialysis patients, CLABSI in dialysis patients was associated with longer catheter duration and line type, even after adjusting for confounders" Morton et al (2026).
"The aim of this study was to retrospectively analyze the incidence and etiology of infections in patients with TIVAD, with a distinction between oncology and hematology patients" Misterka et al (2026).
"This survey of current parenteral nutrition practice reveals some improvements in clinical practice; however, it highlights several critical gaps in the adoption of guidance with ongoing unsafe practices, which can result in patient harm" Ayers et al (2026).
"The objective of this study was to evaluate the frequency of early morning blood draws in 18 hospitals in Ontario, Canada, and to assess variability in phlebotomy practices between institutions and over time" Colacci et al (2026).
"The aim of this study was to evaluate the impact of SE on the diagnostic performance of blood cultures in a high-demand emergency department" Gimeno Gascón et al (2026).
"A multidisciplinary approach integrating infection prevention, stewardship, and patient-centered care is essential to further reduce CLABSI incidence and improve outcomes" Kusnik et al (2026).
"Results showed minor adverse events suggesting that MC may be a safe alternative for the administration of long-term HTS infusions. Midline catheters should be considered when weighing risk and benefits of HTS administration in the management of elevated intracranial pressure and severe hyponatremia" Kundu et al (2026).
"A 24-week TIVAP maintenance interval after completion of intravenous therapy appeared feasible and safe in this real-world cohort, with no infections and excellent port survival" Pina-Cabral et al (2026).
"Clinical pharmacist intervention via implementing infection control within the context of a pharmaceutical-care process can improve infection rates among hemodialysis patients" Obeid et al (2026).
"Reduction of CLABSI rates is a top priority for Level IV NICUs due to the significant short- and long-term impacts for patients. Benchmarking with other NICUs is a valuable practice when neonatal-specific research is unavailable" Velasco et al (2026).
"The rates of tunnelled haemodialysis catheter failure have fallen significantly over the past 25 years. Improvements in catheter outcomes underscore the contemporary importance of an individualised approach to dialysis access" Yaxley et al (2026).
"This study evaluates the efficacy of low-concentration TSC versus low-concentration UFH as CLAs in hemodialysis CVCs" Pattharanitima et al (2026).
